{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:47:31Z","timestamp":1761216451817},"reference-count":44,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":492,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuroendocrinology"],"published-print":{"date-parts":[[2000,8,19]]},"abstract":"<jats:p>Alterations of the hypothalamic\u2010pituitary\u2010adrenal (HPA) axis function characterized by a decreased negative feedback capacity are often associated with affective disorders and are corrected by treatment with antidepressant drugs. To gain a better understanding of the effects of the antidepressant drug fluoxetine, a specific serotonin (5\u2010HT) reuptake inhibitor, on central corticosteroid receptors, the effects of short\u2010term activation of serotonin transmission on central corticosteroid receptor expression were analysed in adrenalectomized (ADX) rats either supplemented or not with corticosterone. Serotonin transmission was stimulated either by a single injection of the 5\u2010HT precursor, 5\u2010hydroxy\u2010 <jats:sc>l<\/jats:sc>\u2010tryptophan (5\u2010HTP), or by a 2\u2010day treatment with fluoxetine. In ADX rats, administration of 5\u2010HTP decreased hippocampal mineralocorticoid (MR) and glucocorticoid (GR) receptor numbers 24\u2003h later, while their respective mRNAs were unchanged and these effects of 5\u2010HTP were mediated by 5\u2010HT<jats:sub>2<\/jats:sub> receptors. In the hypothalamus, GR mRNAs and binding sites decreased 3\u2003h and 24\u2003h after 5\u2010HTP, respectively. By contrast, fluoxetine treatment increased hippocampal MR and GR mRNAs and MR binding sites while GR number remained unchanged. In ADX rats supplemented with corticosterone, 5\u2010HTP and fluoxetine treatment had the same effects on corticosteroid receptors compared to those observed in non supplemented ADX rats: 5\u2010HTP decreased hippocampal MR and GR and hypothalamic GR while fluoxetine treatment increased hippocampal MR. These results show that short\u2010term stimulation of 5\u2010HT transmission by 5\u2010HTP decreases hippocampal and hypothalamic corticosteroid receptor numbers through a corticosterone\u2010independent mechanism. It is hypothesized that the delayed maximal increase in extracellular 5\u2010HT contents after fluoxetine treatment, due to negative feedback regulations induced by the activation of 5\u2010HT<jats:sub>1A<\/jats:sub> and 5\u2010HT<jats:sub>1B<\/jats:sub> autoreceptors, is not the primary cause for the delayed normalization of corticosteroid receptor numbers that regulates the HPA axis functioning.<\/jats:p>","DOI":"10.1046\/j.1365-2826.2000.00509.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T07:09:08Z","timestamp":1047452948000},"page":"736-744","source":"Crossref","is-referenced-by-count":19,"title":["Regulation of Central Corticosteroid Receptors Following Short\u2010Term Activation of Serotonin Transmission by 5\u2010Hydroxy\u2010 <scp>L<\/scp>\u2010Tryptophan or Fluoxetine"],"prefix":"10.1111","volume":"12","author":[{"given":"A.","family":"S\u00e9mont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.\u2010P.","family":"Fache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"H\u00e9ry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Faudon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Youssouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"H\u00e9ry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_16_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0173(93)90005-K"},{"key":"e_1_2_16_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-4328(96)00099-X"},{"key":"e_1_2_16_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.1995.tb00289.x"},{"key":"e_1_2_16_5_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.10"},{"key":"e_1_2_16_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490210113"},{"key":"e_1_2_16_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-117-6-2505"},{"key":"e_1_2_16_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(86)90063-4"},{"key":"e_1_2_16_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.133.5.1941"},{"key":"e_1_2_16_10_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/edrv-17-2-187","article-title":"Antidepressants and hypothalamic\u2010pituitary\u2010adrenocortical regulation","volume":"17","author":"Holsboer F","year":"1996","journal-title":"Endoc Rev"},{"key":"e_1_2_16_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1990.tb16904.x"},{"key":"e_1_2_16_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000126180"},{"key":"e_1_2_16_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.133.1.312"},{"key":"e_1_2_16_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881195009002011"},{"key":"e_1_2_16_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00371-V"},{"key":"e_1_2_16_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(96)00497-6"},{"key":"e_1_2_16_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000054410"},{"key":"e_1_2_16_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90433-C"},{"key":"e_1_2_16_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"e_1_2_16_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000124780"},{"key":"e_1_2_16_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(87)90021-2"},{"key":"e_1_2_16_22_2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1152\/ajpcell.1996.270.5.C1343","article-title":"Corticosteroid receptor mRNA expression is unaffected by corticosteroids in rat kidney, heart, and colon","volume":"270","author":"Escoubet B","year":"1996","journal-title":"Am J Physiol"},{"key":"e_1_2_16_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(86)90659-8"},{"key":"e_1_2_16_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.14.9287"},{"key":"e_1_2_16_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/mend-2-12-1256"},{"key":"e_1_2_16_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1989.tb11887.x"},{"key":"e_1_2_16_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(92)90423-M"},{"key":"e_1_2_16_28_2","first-page":"1319","article-title":"Acute uptake inhibition increases extracellular serotonin in the rat forebrain","volume":"265","author":"Rutter JJ","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_16_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)90214-3"},{"key":"e_1_2_16_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90395-3"},{"key":"e_1_2_16_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199901)31:1<13::AID-SYN3>3.0.CO;2-Y"},{"key":"e_1_2_16_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.67062434.x"},{"key":"e_1_2_16_33_2","doi-asserted-by":"publisher","DOI":"10.1159\/000125250"},{"key":"e_1_2_16_34_2","doi-asserted-by":"publisher","DOI":"10.1210\/mend-3-10-1674"},{"key":"e_1_2_16_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/mend-3-11-1886"},{"key":"e_1_2_16_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.68031159.x"},{"key":"e_1_2_16_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00620-K"},{"key":"e_1_2_16_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90292-C"},{"key":"e_1_2_16_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00573-4"},{"key":"e_1_2_16_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-4328(96)00118-0"},{"key":"e_1_2_16_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199712)27:4<303::AID-SYN4>3.0.CO;2-G"},{"key":"e_1_2_16_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890200306"},{"key":"e_1_2_16_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(95)02159-0"},{"key":"e_1_2_16_44_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0740406.x"},{"key":"e_1_2_16_45_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.6.3239"}],"container-title":["Journal of Neuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2826.2000.00509.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2826.2000.00509.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T11:57:57Z","timestamp":1698580677000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2826.2000.00509.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,19]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000,8,19]]}},"alternative-id":["10.1046\/j.1365-2826.2000.00509.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2826.2000.00509.x","archive":["Portico"],"relation":{},"ISSN":["0953-8194","1365-2826"],"issn-type":[{"value":"0953-8194","type":"print"},{"value":"1365-2826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8,19]]}}}